Search Result "fluvoxamine."


Clinical Characteristics as Predictors of Response to Fluvoxamine, Paroxetine and Milnacipran in Patients with Depression

Journal: Current Psychiatry Reviews
Volume: 1 Issue: 3 Year: 2005 Page: 319-324
Author(s): Shigeru Morishita, Seizabur Arita

The Selective Serotonin Reuptake Inhibitor Paroxetine, but not Fluvoxamine, Decreases Methamphetamine Conditioned Place Preference in Mice

Journal: Current Neuropharmacology
Volume: 9 Issue: 1 Year: 2011 Page: 68-72
Author(s): Y. Takamatsu, H. Yamamoto, Y. Hagino, A. Markou, K. Ikeda

Can the Sigma-1 Receptor Agonist Fluvoxamine Prevent Schizophrenia?

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 8 Issue: 6 Year: 2009 Page: 470-474
Author(s): Kenji Hashimoto

Research Article

Direct UHPLC-DAD Method to Determine Asenapine, Paroxetine and Fluvoxamine in Human Blood Serum, Urine and Cerebrospinal Fluid

Journal: Current Pharmaceutical Analysis
Volume: 12 Issue: 4 Year: 2016 Page: 349-356
Author(s): Leda Kovatsi,Natalia Manousi,Ioannis Papadoyannis

Review Article open access plus

Fluvoxamine and Amantadine: Central Nervous System Acting Drugs Repositioned for COVID-19 as Early Intervention

Journal: Current Neuropharmacology
Volume: 20 Issue: 0 Year: 2022 Page: 1-5
Author(s): Paweł Grieb,Konrad Rejdak

Sigma-1 Receptors and Selective Serotonin Reuptake Inhibitors: Clinical Implications of their Relationship

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 9 Issue: 3 Year: 2009 Page: 197-204
Author(s): Kenji Hashimoto

Molecular Modeling of Two CYP2C19 SNPs and its Implications for Personalized Drug Design

Ebook: Frontiers in Protein and Peptide Sciences
Volume: 1 Year: 2014
Author(s): Jing-Fang Wang,Li-Na Ma,Dong-Qing Wei,Chao Chen,Yixue Li,Kuo-Chen Chou
Doi: 10.2174/9781608058624114010006

Molecular Modeling of Two CYP2C19 SNPs and Its Implications for Personalized Drug Design

Journal: Protein & Peptide Letters
Volume: 15 Issue: 1 Year: 2008 Page: 27-32
Author(s): Dong-Qing Wei, Jing-Fang Wang, Chao Chen, Yixue Li, Kuo-Chen Chou

Sigma-1 Receptor Agonists as Therapeutic Drugs for Cognitive Impairment in Neuropsychiatric Diseases

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 7 Year: 2012 Page: 875-883
Author(s): Tomihisa Niitsu, Masaomi Iyo, Kenji Hashimoto

Clinical Trial

Comparing the Effects of a Herbal Drug based on Echium Amoenum WithFluvoxamine in the Treatment of Adolescents with Obsessive-compulsiveDisorder

Journal: Current Drug Discovery Technologies
Volume: 19 Issue: 5 Year: 2022 Page: 42-48
Author(s): Mohamad Reza Noras,Maryam Hosseini Abrishami

Previous   Next

Go To   Results 1 - 1 of 493

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy